drugset / Trial / NCT07723833
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to measure the pharmacokinetics (PK-how the body processes the study drug) of elecoglipron in healthy participants when taken by mouth as different formulations.
Timeline
- Start
- 2026-07-27
- Primary completion
- 2026-11-18
- Completion
- 2026-11-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elecoglipron | Unknown | — | Oral |
Indications
No indication recorded.